Gov Influence
Menu

Plain-language bill guide

S 1818

S. 1818 is the Prescription Drug Price Relief Act of 2025, categorized by Congress.gov under Health. It was selected through Bernie Sanders's sponsor record and the related Senate health-committee context, adding a concrete prescription-drug measure to the broader healthcare issue group. The captured history reaches introduction and referral to the HELP Committee, so the profile centers on that early procedural position.

Congress.gov resources retrieved Sep 5, 2026 · Source record updated Mar 24, 2026

Editorial illustration of a federal bill folder moving through legislative review steps.

Gov Influence analytical brief

Bottom-line assessment

Gov Influence assessmentPreliminary signal

S 1818's captured procedural record reaches referral; its role here is legislative context, not evidence of a policy outcome.

As of 2025-05-20, the captured official action history reaches referral. Latest recorded action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. The bill appears in 1 reviewed issue group and has 1 matched sponsor profile.

Evidence and reasoning

Reasoning: The assessment combines the deterministic procedural stage with official sponsor identity and a separately reviewed issue-classification basis. Those facts explain where the measure sits in the captured legislative process and why it appears in this collection, while withholding any claim about future momentum, organizational support or opposition, lobbying causation, success, or policy effect.

Scope: S 1818, captured 2025-05-20 through 2025-05-20, within the reviewed Gov Influence collection for S 1818.

Other plausible interpretation

  • The captured Congress.gov history may be superseded by later official action, and a title, policy area, subject, sponsor, or nearby lobbying reference can explain relevance without showing that any organization took a position or affected the bill.

Method: bill-profile-assessment-v1

Editorial review: Gov Influence editorial review; Sep 8, 2026

The captured record shows introduction and referral, not committee approval, Senate passage, enactment, or demonstrated effects on prices or access.

Why this matters

What the pattern adds to the record

S. 1818 is an early-stage health-policy measure in the current record, useful as a precise legislative counterpart to the collection's broader prescription-drug and healthcare disclosures.

Supporting analysis

Key findings

Calculated from recordsHigh confidence

2 distinct milestones summarize where the captured S 1818 record advances—and where it stops.

2025-05-20: introduced; 2025-05-20: referral.

Evidence and reasoning

Reasoning: From the complete captured Congress.gov history, show up to five novice-useful milestones: introduction, the first referral, a committee or report milestone, one passage event per chamber, presidential or enactment action, and the latest action when distinct. Exact duplicates are removed. The selected chronology makes procedural movement visible without repeating administrative rows; the absence of a later selected stage means only that it is not supported by this captured history, not that the bill is permanently inactive or lacks significance.

Scope: S 1818, captured 2025-05-20 through 2025-05-20, within the reviewed Gov Influence collection for S 1818.

Method: bill-action-timeline-v1

Editorial review: Gov Influence editorial review; Sep 8, 2026

Calculated from recordsHigh confidence

S 1818's direct sponsor record is kept separate from issue context and organization references.

Bernie Sanders is matched through the official sponsor identifier. No approved organization subject-reference relationship is present for this bill.

Evidence and reasoning

Reasoning: Sponsor identity is a formal field in the official bill record. Issue placement is a reviewed title, policy-area, or subject classification. An organization link is shown only when an approved subject-reference record exists, and that contextual relationship remains distinct from sponsorship and does not prove support, opposition, contact, coordination, or effect.

Scope: S 1818, captured 2025-05-20 through 2025-05-20, within the reviewed Gov Influence collection for S 1818.

Method: bill-connection-class-v1

Editorial review: Gov Influence editorial review; Sep 8, 2026

Calculated from recordsHigh confidence

The captured Congress.gov action history classifies S 1818 at the referral stage.

As of 2025-05-20, the captured official action history reaches referral. Latest recorded action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 2 official action rows are retained for verification.

Evidence and reasoning

Reasoning: Classify only explicit procedural terms in the captured Congress.gov action text, using the furthest documented stage and making no prediction about later action. The classification reports the furthest supported procedural point in the captured history; it does not predict a next action, measure political momentum beyond that history, or treat referral, reporting, or one-chamber passage as enactment.

Scope: S 1818, captured 2025-05-20 through 2025-05-20, within the reviewed Gov Influence collection for S 1818.

Method: bill-status-v1

Editorial review: Gov Influence editorial review; Sep 8, 2026

Show 1 additional reviewed finding
Reported in the recordHigh confidence

S 1818's issue relevance comes from its official title and policy area.

Official policy area: Health. The captured subjects response contains no subject rows. Reviewed browsing classification: issue-healthcare-drug-policy-medicare.

Evidence and reasoning

Reasoning: The conclusion stays with fields contained in the reviewed Congress.gov resources and the explicit editorial mapping shown on the page. The mapping supports issue navigation and procedural understanding; it does not turn title or subject overlap into a lobbying position, policy evaluation, or causal relationship.

Scope: S 1818, captured 2025-05-20 through 2025-05-20, within the reviewed Gov Influence collection for S 1818.

Method: bill-issue-relevance-v1

Editorial review: Gov Influence editorial review; Sep 8, 2026

Focused starting collection

Why this is in the initial collection

This bill gives the collection a specific prescription-drug record that can be read beside broader Health Issues, Pharmacy, and Medicare/Medicaid filings. The sponsor identifier creates a direct connection to Sanders, and his selected HELP Committee role supplies relevant institutional context. Together they explain why S. 1818 appears here while leaving policy evaluation, organizational positions, and potential effects to evidence not contained in this packet.

What this edition covers: The page presents the official title, Health policy area, sponsor, and captured action history through Senate committee referral.

Questions this page helps answer

  • What health subject does the bill identify?
  • What stage has it reached?
  • How does the sponsor and committee context fit?

Evidence paths kept distinct

Direct and contextual connections

Sponsorship is a direct official relationship. Issue and organization links identify the narrower subject basis that makes each browsing path useful.

Verified relationshipDirect sponsor record

See Bernie Sanders’s reviewed official profile

Why connected: The Congress.gov bill record’s sponsor identifier matches this approved public-official profile.

Sponsorship documents who introduced the measure. It does not create an organization relationship or establish the bill’s merit, effect, or prospects.

Context onlySubject context

Compare the bill with Healthcare, Prescription Drugs and Medicare

Why connected: Reviewed classification based on the official Health policy area and bill title; it does not state a position on the bill.

This title, policy-area, or subject overlap explains the browsing path. It does not establish lobbying activity, a policy position, or causation.

No organization relationship has passed review for this bill. None is added from a shared topic, date, name, sponsor, or committee alone.

Legislative record

Current status in the captured official record

As of 2025-05-20, the captured official action history reaches referral. Latest recorded action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Referral sends the bill to a committee for consideration; it is not committee approval or passage.

  1. IntroducedRecordedA bill record was created in its originating chamber.
  2. Referral / committeeCurrent captured stageReferral, committee work, or reporting appears in the record.
  3. Passed one chamberNot reached in captured recordEither the House or Senate recorded passage.
  4. Passed both chambersNot reached in captured recordBoth chambers recorded passage of the measure.
  5. Presidential actionNot reached in captured recordThe measure reached the President.
  6. Became lawNot reached in captured recordThe official history records enactment.

How status is determined: Classify only explicit procedural terms in the captured Congress.gov action text, using the furthest documented stage and making no prediction about later action. Reviewed Sep 4, 2026.

Key actions for understanding the bill’s path

The captured record supports 2 distinct milestones selected for a quick reading. When fewer than three distinct milestones exist, the page shows only the supported actions rather than repeating or inventing an event.

  1. Introduced

    Bill introduced

  2. Referral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

This is a selected procedural chronology, not every vote, amendment, motion, communication, or administrative action. Use the official all-actions link for the complete captured category.

How the key actions were selected

From the complete captured Congress.gov history, show up to five novice-useful milestones: introduction, the first referral, a committee or report milestone, one passage event per chamber, presidential or enactment action, and the latest action when distinct. Exact duplicates are removed.

Legislative record

Official bill facts and complete captured detail

The most useful facts stay visible. Long action, subject, committee, and source lists remain available in the disclosures below.

Official title
Prescription Drug Price Relief Act of 2025
Congress
119
Bill type and number
S 1818
Introduced
May 20, 2025
Policy area
Health
Latest action date
May 20, 2025
Cosponsors
7

Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

The official cosponsor count is a formal record field, not a prediction or a complete measure of support. Individual cosponsor names are not reproduced here.

Show all 2 captured official action rows

Complete captured action history, newest first. Repeated rows are preserved when supplied by the official response.

  1. IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. IntroReferral

    Introduced in Senate

Check the captured legislative-subject response

Subjects are Congress.gov indexing terms, not Gov Influence claims about policy merit, position, or effect.

Congress.gov supplied no legislative-subject rows in the captured subjects response. This does not mean the bill has no subject matter.

Show all 1 captured committee entries

Rows reproduce the captured Congress.gov committee resource. “None listed” describes this response, not every possible committee activity.

Official committee entries
ChamberCommitteeTypeSubcommittees listed
SenateHealth, Education, Labor, and Pensions CommitteeStandingNone listed in captured record
Show all mapped official source records

Continue with context

Learn how to read the record